- Home
- IHT vs IMRN Comparison
IHT vs IMRN Comparison
Compare IHT & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IHT | IMRN |
|---|---|---|
| Founded | 1971 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 12.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IHT | IMRN |
|---|---|---|
| Price | $1.40 | $1.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.5K | ★ 1.3M |
| Earning Date | 12-26-2025 | 08-29-2025 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,463,789.00 | $4,777,422.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 48.63 |
| 52 Week Low | $1.25 | $1.00 |
| 52 Week High | $4.24 | $2.48 |
Technical Indicators
Market Signals| Indicator | IHT | IMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 26.69 |
| Support Level | $1.25 | $1.00 |
| Resistance Level | $1.49 | $1.78 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 55.56 | 2.56 |
Price Performance
Historical ComparisonAbout IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.